GIGulmira Maratovna Iztleuova

Gulmira Maratovna Iztleuova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gulmira Maratovna Iztleuova has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Trace Elements and Psoriasis: Current Perspectives and the Role of Heavy Metals

    by Gulmira M. Iztleuova, Nurgul Nurlankyzy Alen, Aitolkyn E. Andreeva, Altynai M. Orazova, Altynai Zh. Azamat, Aidana B. Bukembaeva

    A BSTRACT: Psoriasis is a chronic immune-mediated inflammatory skin disease with systemic manifestations, associated with a marked reduction in quality of life and an increased risk of complications. In recent years, growing attention has been paid to the role of trace elements and heavy metals in the pathogenesis of psoriasis, as they can influence key pathogenic mechanisms, including oxidative stress and immune processes. The aim of this review was to summarize current evidence on the role of trace elements and heavy metals in the development and clinical course of psoriasis. PubMed and Google Scholar were searched for publications from January 2016 to June 2026 using predefined combinations of terms related to psoriasis, trace elements, heavy metals, and oxidative stress. Earlier landmark studies were additionally considered when necessary to describe established biological mechanisms. The available literature suggests that alterations in essential trace elements, particularly zinc and selenium, are associated with oxidative stress, inflammatory activity, and psoriasis severity, although findings for copper, magnesium, and other elements are heterogeneous. Observational studies have also reported associations between exposure to certain toxic metals and psoriasis-related outcomes; however, the current evidence does not establish causality. The environmental context of Western Kazakhstan provides a rationale for further region-specific investigation, but direct evidence linking regional heavy metal exposure to psoriasis severity remains limited. These findings support further study of trace element status and environmental exposures as potential modifiers of psoriasis rather than established determinants of disease course.

  • Association of Vaginal Microbiota Composition with Human Papillomavirus Persistence in Cervical Dysplasia and Cervical Cancer: A Systematic Review and Meta-Analysis

    by Elyanora Askarovna Kydyrbayeva, Yerbolat Maratovich Iztleuov, Indira Azamatkyzy Azamatova, Gulmira Maratovna Iztleuova, Yerlan Bakhytovich Sultangereyev, Nurgul Abdullaevna Abenova

    Introduction: Persistent high-risk human papillomavirus (hrHPV) infection is the main step in cervical carcinogenesis. The vaginal microbiota may modulate this risk, but the evidence is heterogeneous. This is because previous reviews have not provided a quantitative synthesis that specifically examines the persistence of HPV in the full progression of disease from dysplasia to invasive cancer. This specific gap reduces the transition of microbiota research into the stratification of clinical risks. The aim of the research is to systematically review and meta-analyze the association between the composition of the vaginal microbiota and hrHPV persistence in women with cervical dysplasia and cancer. Methods: The researcher searched PubMed, Embase, Cochrane Library, and Web of Science (Jan 2015-Feb 2026) for observational studies. Pooled odds ratios (ORs) were calculated using a random-effects model. Study quality was assessed using the Newcastle-Ottawa Scale. Results: Twenty-four studies were included. A non-Lactobacillus-dominant microbiota was related with 2.5 times higher odds of hrHPV persistence (pooled OR 2.51, 95% CI 1.95-3.23, I²=68%, 18 studies). The relationship was stronger in women with invasive cervical cancer (OR 3.40) than in those with dysplasia only (OR 2.15). Conclusion: Vaginal dysbiosis is significantly related to hrHPV persistence, with a significant effect in cervical cancer. The vaginal microbiome represents a potential biomarker for the stratification of risk and a target for therapeutic intervention.

  • Open Access

    POTENTIAL OTOTOXIC EFFECTS OF DIFFERENT GENERATIONS OF EGFR TYROSINE KINASE INHIBITORS: A LITERATURE REVIEW

    by L.S. Balymbetova, Y.M. Iztleuov, E.K. Ismagulova, S.K. Kozhantayeva, G.M. Iztleuova

    Relevance: Lung cancer is one of the most frequent malignant tumors, and non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases. Mutations in the epidermal growth factor receptor (EGFR) gene contribute significantly to NSCLC development. EGFR is key for tumor occurrence and progression. The discovery of tyrosine kinase inhibitors (TKI) targeting EGFR has marked significant progress, offering a more rational and effective therapeutic approach. However, TKIs are not free of side effects. Evidence indicates a potential link between TKI therapy and ototoxicity. Given the chronic nature of the treatment of patients with advanced stages of the disease, even minor toxicity can significantly affect the quality of life. It is essential to inform patients about the potential risk of hearing impairment and to regularly monitor for early signs of ototoxicity, thereby optimizing long-term treatment outcomes for patients. The study aimed to review the existing data on tyrosine kinase inhibitors and their potential ototoxicity, including the main mechanisms of pathogenesis. Methods: The search utilized PubMed, Scopus, Embase, Cochrane Library, Web of Science, Google Scholar, and ClinicalTrials.gov to identify scientific publications on ototoxicity caused by TKIs in NSCLC. The keywords “non-small cell lung cancer,” “ototoxicity,” “gefitinib,” “erlotinib,” “afatinib,” “dacomitinib,” and “osimertinib” were used for the search. Results: EGFR plays an important role in developing, maintaining, and repairing sensory and non-sensory structures of the inner ear. In neonatal models, EGFR is expressed in cochlear cells, including the cortical organ, facilitating regeneration and repair. However, in mature systems, EGFR expression decreases, primarily localized in the spiral ganglion, limiting the regenerative ability of auditory cells. By inhibiting EGFR signaling, cellular proliferation and repair mechanisms are disrupted, damaging the cochlea’s hair cells and supporting cells. Conclusion: The prevalence and main molecular mechanisms of ototoxicity caused by TKI remain poorly understood. Further research is needed to clarify dose-dependent effects, genetic predisposition, and potential protective strategies. Knowledge of this adverse effect is necessary to monitor auditory health during EGFR-TKI therapy and to study interventions that mitigate its effects on patients undergoing long-term treatment.

  • Open Access

    POTENTIAL OTOTOXIC EFFECTS OF DIFFERENT GENERATIONS OF EGFR TYROSINE KINASE INHIBITORS: A LITERATURE REVIEW

    by Л.с. Балымбетова, Y. Iztleuov, Э.к. Исмагулова, S. Kozhantayeva, Г.м. Изтлеуова, Е.м. Изтлеуов

    Relevance: Lung cancer is one of the most frequent malignant tumors, and non-small cell lung cancer (NSCLC) accounts for approximately 85% of all cases. Mutations in the epidermal growth factor receptor (EGFR) gene contribute significantly to NSCLC development. EGFR is key for tumor occurrence and progression. The discovery of tyrosine kinase inhibitors (TKI) targeting EGFR has marked significant progress, offering a more rational and effective therapeutic approach. However, TKIs are not free of side effects. Evidence indicates a potential link between TKI therapy and ototoxicity. Given the chronic nature of the treatment of patients with advanced stages of the disease, even minor toxicity can significantly affect the quality of life. It is essential to inform patients about the potential risk of hearing impairment and to regularly monitor for early signs of ototoxicity, thereby optimizing long-term treatment outcomes for patients. The study aimed to review the existing data on tyrosine kinase inhibitors and their potential ototoxicity, including the main mechanisms of pathogenesis. Methods: The search utilized PubMed, Scopus, Embase, Cochrane Library, Web of Science, Google Scholar, and ClinicalTrials.gov to identify scientific publications on ototoxicity caused by TKIs in NSCLC. The keywords “non-small cell lung cancer,” “ototoxicity,” “gefitinib,” “erlotinib,” “afatinib,” “dacomitinib,” and “osimertinib” were used for the search. Results: EGFR plays an important role in developing, maintaining, and repairing sensory and non-sensory structures of the inner ear. In neonatal models, EGFR is expressed in cochlear cells, including the cortical organ, facilitating regeneration and repair. However, in mature systems, EGFR expression decreases, primarily localized in the spiral ganglion, limiting the regenerative ability of auditory cells. By inhibiting EGFR signaling, cellular proliferation and repair mechanisms are disrupted, damaging the cochlea’s hair cells and supporting cells. Conclusion: The prevalence and main molecular mechanisms of ototoxicity caused by TKI remain poorly understood. Further research is needed to clarify dose-dependent effects, genetic predisposition, and potential protective strategies. Knowledge of this adverse effect is necessary to monitor auditory health during EGFR-TKI therapy and to study interventions that mitigate its effects on patients undergoing long-term treatment.

  • Open Access

    The role of intestinal microbiota in the pathogenesis of nephropathy in patients with metabolic syndrome; a systematic review

    by Talgar Abilov, Gulmira Iztleuova, Sarkyt Kozhantayeva, Zhangeldy Shaimbetov, Yerbolat Iztleuov

    Introduction: The gut microbiota plays a vital role in maintaining metabolic and renal health. Dysbiosis associated with metabolic syndrome contributes to the development of nephropathy through mechanisms involving inflammation and the production of uremic toxins. Objectives: This study aims to examine the role of the intestinal microbiota in the onset and progression of nephropathy in patients with metabolic syndrome, particularly its impact on renal function. Methods: A systematic review was conducted covering the period from 2020 to 2025, following PRISMA guidelines. Relevant literature on gut microbiota, nephropathy, and metabolic syndrome was identified through databases including Scopus, Web of Science, Cochrane Library, PubMed, and Europe PMC. The quality of included studies was assessed using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale to ensure methodological rigor. Results: The 16 included studies varied in design, study populations, and duration. All reported a reduction in microbial diversity among patients with chronic kidney disease (CKD) and nephropathy. The presence of Prevotella and Faecalibacterium was generally associated with improved kidney function, whereas disease progression correlated with higher levels of Proteobacteria and Clostridium. Metabolites such as indoxyl sulfate and p-cresol glucuronide were commonly linked to nephropathy. Interventions such as probiotic supplementation, fecal microbiota transplantation (FMT), and time-restricted feeding (TRF) showed potential in stabilizing the estimated glomerular filtration rate, reducing uremic toxins, and slowing disease progression. Conclusion: The gut microbiota and its metabolites significantly influence the development and progression of nephropathy in the context of metabolic syndrome. Modulating microbial composition through probiotics and dietary interventions may help restore renal function and mitigate disease advancement. Registration: This review was conducted in accordance with the PRISMA checklist, and the protocol was registered with PROSPERO (ID: CRD420251053100).

  • Open Access

    Prognostic Role of Breast Architecture in Imaging, Histopathology, and Breast Cancer Outcome

    by Yerbolat Iztleuov, Gulbanu Mutigulina, Altyn Almagambetova, Gulmira Iztleuova

    Aims. This study investigates the prognostic significance of mammographic density in breast cancer detection, histopathological patterns, treatment outcomes, and the diagnostic efficacy of different imaging modalities. Methods. A retrospective analysis was conducted using data from approximately 7,000 women (20% of the annual screening cohort of 35,000) over the 10-year period. Breast density was classified using BI-RADS categories (A–D). The frequency of breast cancer detection in each density category was analyzed. Imaging methods included mammography, ultrasound, and MRI. Recommendations for women with high-density breasts were developed based on findings. Results. High breast density (BI-RADS C and D) was identified in approximately 60% of screened women. Breast cancer detection rates were significantly higher in BI-RADS C (55%) and BI-RADS D (60%) groups compared to BI-RADS A (12%) and BI-RADS B (15%). Tumor sizes were larger in high-density breasts (2.5 cm for BI-RADS C, 2.8 cm for BI-RADS D). Mammography sensitivity decreased in dense breasts, whereas ultrasound and MRI showed higher sensitivity (90–97%). Based on these findings, guidelines for women with high-density breasts were proposed, emphasizing supplemental imaging and personalized screening. Conclusion. High mammographic density is associated with aggressive tumour types, larger tumour sizes, and poorer outcomes. Aims. This study investigates the prognostic significance of mammographic density in breast cancer detection, histopathological patterns, treatment outcomes, and the diagnostic efficacy of different imaging modalities. Methods. A retrospective analysis was conducted using data from approximately 7,000 women (20% of the annual screening cohort of 35,000) over the 10-year period. Breast density was classified using BI-RADS categories (A–D). The frequency of breast cancer detection in each density category was analyzed. Imaging methods included mammography, ultrasound, and MRI. Recommendations for women with high-density breasts were developed based on findings. Results. High breast density (BI-RADS C and D) was identified in approximately 60% of screened women. Breast cancer detection rates were significantly higher in BI-RADS C (55%) and BI-RADS D (60%) groups compared to BI-RADS A (12%) and BI-RADS B (15%). Tumor sizes were larger in high-density breasts (2.5 cm for BI-RADS C, 2.8 cm for BI-RADS D). Mammography sensitivity decreased in dense breasts, whereas ultrasound and MRI showed higher sensitivity (90–97%). Based on these findings, guidelines for women with high-density breasts were proposed, emphasizing supplemental imaging and personalized screening. Conclusion. High mammographic density is associated with aggressive tumour types, larger tumour sizes, and poorer outcomes.

  • Open Access

    Prevention of Chromium-Induced Radiation-Chemical Oncogenesis, Including in Offspring, in an Experimental Model: A Systematic Review

    by Marat Iztleuov, Yerbolat Iztleuov, Talgar Abilov, Gulmira Iztleuova, Elyanora Kydyrbayeva, Nauryzbay Imanbayev

    Radiation and chemical-induced cancer are of increasing concern as the various activities of humans continuously elevate the levels of radiation and toxic chemicals in the environment. The prevention of this incidence using alternative medicines-phytopreparations, therefore, becomes pertinent as conventional approaches tend to produce various unwanted side effects. To achieve this, there is a need to understand the various mechanisms of action through which phytopreparations exhibit their protective effects. This systematic review, therefore, aims to explore the mechanism of action of various phytopreparations in the prevention of induced radiation and chemical (chromium) cancer. A systematic review approach following the stipulated guidelines by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was used to identify research papers published between 2015 and 2025. Four databases, namely Europe PubMed Central (PMC), PubMed, Springer Open, and Wiley Online Library were used to search for related open access papers. A total of 621 research papers were reviewed for suitability to the review objective; however, only five papers met the inclusion criteria, and an additional two papers were sourced from ResearchGate. Thus, a total of seven papers were finally included in the analysis. This review highlights the mechanisms of action of various phytopreparations in the prevention of radiation and chromium-induced cancer. The major mechanisms of phytopreparations’ action in the prevention of induced radiation and chromium oncogenesis majorly involve regulating pro and anti-inflammatory cytokines, improving cell-to-cell communication, and preventing damage to DNA structure.

  • Open Access

    DYNAMIC ASSESSMENT OF QUALITY OF LIFE ASSOCIATED WITH VISUAL IMPAIRMENT IN PATIENTS RECEIVING CHEMOTHERAPY

    by R.M. Irmekbayev, Y.M. Iztleuov, Ye.T. Muratov, T.S. Abilov, G.M. Iztleuova, R. Irmekbaev, E. Muratov

    Introduction: Chemotherapy and targeted therapy used in cancer treatment are often associated with side effects that affect visual function. Such complications include dry eye syndrome, cataracts, keratopathy, and retinopathy, which can significantly worsen patients’ quality of life. This work focuses on assessing the quality of life of cancer patients experiencing visual impairment and the importance of monitoring these side effects.The study aimed to explore the quality of life of cancer patients with visual impairments resulting from exposure to chemotherapy and targeted therapy, with special attention to the timing of visual complications, their severity, and reversibility.Methods: The study analyzed 65 scientific articles in Russian and English published in PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar databases from 2012 to 2024. The search used keywords related to chemotherapy, toxic effects on vision, and malignant neoplasms. The study included meta-analyses, systematic reviews, controlled clinical trials, and individual case reports.Results: Chemotherapeutic drugs such as cisplatin and paclitaxel cause visual impairment, including dry eye syndrome, red eyes, cataracts, and retinopathy. Targeted drugs such as bevacizumab and erlotinib cause corneal damage, conjunctivitis, and uveitis. Visual impairment significantly worsens patients’ quality of life, creating difficulties in performing everyday tasks such as reading, driving, and recognizing faces. These impairments also cause discomfort, dry eyes, and lacrimation and can lead to decreased visual acuity. In rare cases, the consequences of such impairments lead to partial or complete loss of vision, which seriously affects the patient’s social functioning and emotional state. The use of special ophthalmological questionnaires allows for the early detection of side effects, which helps improve patients’ quality of life.Conclusion: Dynamic quality of life assessment represents a promising approach to understanding and addressing visual impairment in patients receiving chemotherapy and targeted therapy. These methods consider temporal variations and contextual factors that influence quality of life, opening the way for personalized interventions that may improve treatment outcomes.

  • Open Access

    DYNAMIC ASSESSMENT OF QUALITY OF LIFE ASSOCIATED WITH VISUAL IMPAIRMENT IN PATIENTS RECEIVING CHEMOTHERAPY

    by R. Irmekbayev, Y. Iztleuov, Ye. Muratov, Т.с. Абилов, Г.м. Изтлеуова, Р.м. Ирмекбаев, Е.м. Изтлеуов, Е.т. Муратов

    Introduction: Chemotherapy and targeted therapy used in the treatment of cancer are often accompanied by side effects that affect visual function. Such complications include dry eye syndrome, cataracts, keratopathy, and retinopathy, which can significantly worsen patients’ quality of life. This work focuses on assessing the quality of life of cancer patients experiencing visual impairment and the importance of monitoring these side effects. Objective: To study the quality of life of cancer patients with visual impairments resulting from exposure to chemotherapy and targeted therapy, with special attention to the timing of visual complications, their severity, and reversibility. Materials and methods: The study analyzed 65 scientific articles in Russian and English published in PubMed, Embase, Cochrane Library, Scopus, Web of Science, and Google Scholar databases from 2012 to 2024. The search used keywords related to chemotherapy, toxic effects on vision, and malignant neoplasms. The study included meta-analyses, systematic reviews, controlled clinical trials, and individual case reports. ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ 34 Онкология и Радиология Казахстана, №1 (75) 2025 Прозрачность исследования: Авторы несут полную ответственность за содержание данной статьи. Конфликт интересов: Авторы заявляют об отсутствии конфликта интересов. Финансирование: работа выполнена в рамках научного проекта с грантовым финансированием Комитета науки Министерства науки и высшего образования Республики Казахстан "АР19678225 Профилактика спонтанного онкогенеза у первого поколения крыс, родители которого подвергались воздействию гамма-облучения и хрома (эксперимент)" (рег. номер 0123РК00613). Вклад авторов: вклад в концепцию – Ирмекбаев Р.М., Изтлеуов Е.М.; научный дизайн – Муратов Е.Т., Изтлеуов Е.М.; исполнение заявленного научного исследования – Изтлеуов Е.М., Муратов Е.Т., Авизова З.К.; интерпретация заявленного научного исследования – Изтлеуов Е.М., Абилов Т.С.; создание научной статьи – Изтлеуов Е.М., Изтлеуова Г.М. Сведения об авторах: Ирмекбаев Р.М. – докторант НАО «ЗКМУ имени Марата Оспанова», ассистент кафедры офтальмологии, Актобе, Республика Казахстан, тел. +77762927416, e-mail: ruslan_xdrive@mail.ru, ORCID: 0009-0004-1138-3884; Изтлеуов Е.М. (корреспондирующий автор) – асс.проф., к.м.н., руководитель кафедры радиологии НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77756988866, e-mail: ermar80@mail.ru, ORCID: 0000-0002-5303-8593; Муратов Е.Т. – докторант НАО «ЗКМУ имени Марата Оспанова», ассистент кафедры офтальмологии, Актобе, Республика Казахстан, тел. 87057670044, e-mail: yesssset@gmail.com, ORCID: 0000-0002-9542-5962; Авизова З.К. – докторант НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77477935005, e-mail: zeinepavizova@gmail.com, ORCID: 0000-0001-5540-0229; Абилов Т.С. – к.м.н., в.и.о. НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел +77022272813; e-mail: abilovtalgar@gmail.com ORCID:0009-0001-8417-7924; Изтлеуова Г.М. – к.м.н., заведующий курсом дерматовенерологии НАО «ЗКМУ имени Марата Оспанова», Актобе, Республика Казахстан, тел. +77078818666; ORCID: 0000-0002-5695-0895. Адрес для корреспонденции: Изтлеуов Е.М., НАО ЗКМУ имени Марата Оспанова, ул. Маресьева 68, Актобе 030000, Республика Казахстан. Results: Chemotherapeutic drugs such as cisplatin and paclitaxel cause visual impairment, including dry eye syndrome, red eyes, cataracts, and retinopathy. Targeted drugs such as bevacizumab and erlotinib cause corneal damage, conjunctivitis, and uveitis. Visual impairment significantly worsens patients’ quality of life, creating difficulties in performing everyday tasks such as reading, driving, and recognizing faces. These impairments also cause discomfort, dry eyes, and lacrimation and can lead to decreased visual acuity. In rare cases, the consequences of such impairments lead to partial or complete loss of vision, which seriously affects the patient’s social functioning and emotional state. The use of special ophthalmological questionnaires allows for the early detection of side effects, which helps improve patients’ quality of life. Conclusion: Dynamic quality of life assessment represents a promising approach to understanding and addressing visual impairment in patients receiving chemotherapy and targeted therapy. By considering temporal variations and contextual factors that influence quality of life, these methods open the way for personalized interventions that may improve treatment outcomes.

  • Open Access

    Prevention of Mutagenesis, Oxidative Stress and Inflammation in first Generation Male Rats whose Parents are Exposed to Gamma Radiation and Hexavalent Chromium

    by Yerbolat Iztleuov, Marat Iztleuov, Altynbek Dushmanov, Elyanora Kydyrbayeva, Gulbanu Mutigulina, Nauryzbay Imanbayev, Gulmira Iztleuova

    Introduction: Children exposed to radiation chemical agents or born to exposed parents faced elevated risks of stochastic pathologies, including genetic disorders, tumours, and leukaemia. These risks were attributed to mutations and latent genomic damage caused by such exposures. Methods: This six-month experimental study at NAO ZKMU in Kazakhstan evaluated Burdock Root Oil's protective effects against gamma radiation and hexavalent chromium-induced damage in 100 Wistar rats, analyzed using Statistica 10.Results: The findings revealed that the offspring of parents exposed to combined chromium and gamma irradiation (Cr⁶⁺ + γ) exhibited a 33% increase in micronuclei (6.3 ±1.16‰, P ≤ 0.01) compared to controls (4.56 ± 1.18‰), indicating significant genotoxicity. Burdock Root Oil reduced micronuclei levels to 5.34 ± 0.792‰ (P≥ 0.05), comparable to control levels. Chromosomal aberrations in the Cr⁶⁺+ γgroup increased by 54% (2.77 ± 0.537%, P ≤ 0.001), while Burdock Root Oil reduced total aberrations by 19.5% (P ≤ 0.005). Markers of oxidative stress showed significant improvement; superoxide dismutase (SOD) activity increased by 16.7%, catalase by 22.6%, and sulfhydryl groups by 23% (P≤ 0.05), while malondialdehyde levels decreased by 16% (P ≤ 0.05). The SH/MDA ratio increased by 45% (P ≤ 0.05).Conclusions: Burdock Root Oil effectively mitigated genotoxic, oxidative, and inflammatory effects in the offspring of parents exposed to gamma radiation and chromium. It restored immune balance, reduced oxidative stress, and preserved genomic stability